Effectiveness of Intermittent Vacuum Therapy Combined with Aerobic Exercise in Individuals with Diabetes Mellitus
1 other identifier
interventional
12
1 country
1
Brief Summary
Consequences of the compromised vascular system in diabetes mellitus (DM) are among the most devastating complications. Reduction in blood flow and oxygen uptake of skeletal muscle leads to muscle fatigue and impaired skeletal muscle post-exercise adaptation. Recent studies showed that intermittent vacuum therapy (IVT) augments the blood flow of the foot in people with DM. This pilot study investigates the effects of combined IVT and aerobic exercise in improving lower limb muscle oxygenation and distal circulation in individuals with DM. Positive results of the study shed light on strategy that enhances the effectiveness of aerobic exercise in people with DM.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable diabetes-mellitus
Started Aug 2023
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
August 1, 2023
CompletedFirst Submitted
Initial submission to the registry
February 27, 2024
CompletedFirst Posted
Study publicly available on registry
March 5, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 30, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
April 30, 2025
CompletedMarch 12, 2025
February 1, 2025
1.7 years
February 27, 2024
March 9, 2025
Conditions
Outcome Measures
Primary Outcomes (2)
Muscle oxygenation
Two wireless NIRS (Near-infrared Spectroscopy) sensors (Portamon, Artinis Medical Systems,The Netherlands) will be placed on participants' dorsal feet and quadriceps on their dominant leg. The signal will be collected continuously for 10 minutes during cycling.
baseline
Muscle oxygenation
Two wireless NIRS sensors (Portamon, Artinis Medical Systems,The Netherlands) will be placed on participants' dorsal feet and quadriceps on their dominant leg. The signal will be collected continuously for 10 minutes during cycling.
post-treatment (6weeks)
Secondary Outcomes (8)
Surface Electromyography
baseline
Surface Electromyography
post-treatment (6weeks)
Foot Sensation
baseline
Foot Sensation
post-treatment (6weeks)
Functional muscle strength
baseline
- +3 more secondary outcomes
Study Arms (1)
Intermittent vacuum therapy + Cycling exercise
EXPERIMENTALParticipants received 12 IVT sessions of 30 minutes combined with 20 minutes of cycling exercise during the 6-week period.
Interventions
The participants' lower limb will be placed in the vacuum chamber and sealed with a cuff. The maximum negative pressure applied in the experimental group would be -40mmHg (negative pressure/ambient pressure phase: 9s / 7s). The parameters are selected based on the manufacturer's recommendations.
The participant will perform 20 minutes of cycling exercise. Aiming at reaching a moderate exercise intensity (50% - 70%) of maximal heart rate on a gym bike.
Eligibility Criteria
You may qualify if:
- age between 55 and 80 years old,
- being diagnosed with Type 2 DM,
- being able to give informed consent to participate in the study.
- able to walk without assistance
You may not qualify if:
- have a conditions that contraindications to IVT: pregnancy, abdominal wall hernia, recent (\<8 weeks) trauma of the lower limbs,
- have an open wound on the lower extremity or with lower extremity infection,
- have any orthopaedic or medical conditions that could hinder the assessment and training.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
The Hong Kong Polytechnic University
Hong Kong, Hong Kong
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
February 27, 2024
First Posted
March 5, 2024
Study Start
August 1, 2023
Primary Completion
April 30, 2025
Study Completion
April 30, 2025
Last Updated
March 12, 2025
Record last verified: 2025-02
Data Sharing
- IPD Sharing
- Will not share
Individual participant data will not be shared to other researchers